References
- Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179(3):1634–1647.
- Spach KM, Nashold FE, Dittel BN, et al. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol. 2006;177(9):6030–6037.
- Martinelli V, Dalla Costa G, Colombo B, et al. Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes. Mult Scler J. 2014;20(2):147–155.
- Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.
- Benamer HTS, Ahmed ESM, Al-Din AS, et al. Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review. J Neurol Sci. 2009;278(1–2):1–4. DOI:10.1016/j.jns.2008.12.001
- Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–1452.
- Wiens AN, Fuller KH, Crossen JR. Paced auditory serial addition test: adult norms and moderator variables. J Clin Exp Neuropsychol. 1997;19(4):473–483. DOI:10.1080/01688639708403737
- Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. DOI:10.1210/jc.2011-0385
- Alroughani R, Al Hashel J, Lamdhade S, et al. Predictors of conversion to multiple sclerosis in patients with clinical isolated syndrome using the 2010 revised McDonald criteria. ISRN Neurol. 2012;2012:792192.
- Zamzam D, Fouad M, Elaidy D, et al. Vitamin D levels in a sample of Egyptian patients with multiple sclerosis. Egypt J Neurol Psychiatry Neurosurg. 2016;53(2):107.
- Al-Mohaimeed A, Khan NZ, Naeem Z, et al. Vitamin D status among women in middle East. J Heal Sci. 2012;2(6):49–56.
- Moen SM, Celius EG, Sandvik L, et al. Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study. PLoS One. 2012;7(9):e45703. DOI:10.1371/journal.pone.0045703
- Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832. DOI:10.1001/jama.296.23.2832
- Beretich B, Beretich T. Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis. Mult Scler J. 2009;15(8):891–898. DOI:10.1177/1352458509105579
- Munger KL, Chitnis T, Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology. 2009;73(19):1543–1550. DOI:10.1212/WNL.0b013e3181c0d6e0
- Lemire JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem. 1992;49(1):26–31.
- Ramagopalan SV., Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009;5(2):e1000369.
- Feinstein A, Kartsounis LD, Miller DH, et al. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study. J Neurol Neurosurg Psychiatry. 1992;55(10):869–876.
- Feuillet L, Reuter F, Audoin B, et al. Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler J. 2007;13(1):124–127.
- Johansson P, Almqvist EG, Johansson J-O, et al. Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease. PLoS One. 2013;8(11):e81989.
- Pettersen JA. Vitamin D and executive functioning: are higher levels better? J Clin Exp Neuropsychol. 2016;38(4):467–477.
- Annweiler C, Schott A-M, Berrut G, et al. Vitamin D and ageing: neurological issues. Neuropsychobiology. 2010;62(3):139–150.
- Tay SH, Ho CS, Ho RC-M, et al. 25-Hydroxyvitamin D3 deficiency independently predicts cognitive impairment in patients with systemic lupus erythematosus. PLoS One. 2015;10(12):e0144149.
- Thouvenot E, Orsini M, Daures J-P, et al. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis. Eur J Neurol. 2015;22(3):564–569.
- Ascherio A, Munger KL, White R, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol. 2014;71(3):306.
- Mowry EM, Pelletier D, Gao Z, et al. Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection. Eur J Neurol. 2016;23(2):327–332.